Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 15,600 IMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | ImageneBio, Inc. (IMA) | Grant/Award | 15,600 | n/a |
| Jul 30, 2025 | ImageneBio, Inc. (IMA) | Exercise/Conversion | 379 | n/a |
| Jun 10, 2024 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 17,520 | n/a |
| Nov 10, 2023 | Lexeo Therapeutics, Inc. (LXEO) | Conversion | 1,415,865 | n/a |
| Jun 13, 2023 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 17,520 | n/a |
| Jun 13, 2022 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 13,419 | n/a |
| Mar 17, 2022 | Replimune Group, Inc. (REPL) | Exercise/Conversion | 16,500 | $161.4K |
| Dec 23, 2021 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 13,419 | n/a |
| Nov 23, 2021 | Replimune Group, Inc. (REPL) | Sale | 34,845 | $1.20M |
| Nov 18, 2021 | Replimune Group, Inc. (REPL) | Sale | 153 | $5.1K |